COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

- Tomlinson, I. P. M., Dunlop, M., Aaltonen, L. A., Hemminki, K., Lindblom, A., Forsti, A., Sieber, O., Lipton, L., van Wezel , T., Morreau, H., Wijnen, J. T., Devilee, P., Campbell, H., Scott, R., Zanke, B., Gallinger, S., Hudson, T., Koessler, T., Pharoah, P. D., Niittymakix, I., Tuupanenx, S.

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer

- Bernhard, J., Zahrieh, D., Green, M. D., Colleoni, M., Gelber, R. D., Castiglione-Gertsch, M., Price, K. N., Goldhirsch, A., Coates, A. S., Zhang, J. J., Martinelli, G., Basser, R., Hurny, C., Forbes, J. F., Aebi, S., Yeo, W., Thurlimann, B.

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

- Wagner, U., Marth, C., Gebski, V., Lauraine, E. P., Largillier, R., Kaern, J., Brown, C., Heywood, M., Bonaventura, T., Vergote, I., Piccirillo, M. C., Fossati, R.

O⁶-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib

- Watson, A. J., Middleton, M. R., Haydon, A., Kefford, R., Lorigan, P., Mortimer, P., Sabharwal, A., Hayward, O., Margison, G. P., McGown, G., Thorncroft, M., Ranson, M., Hersey, P., McArthur, G., Davis, I. D., Thomson, D., Beith, J.

Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trial

- Sestak, I., Kealy, R., Nikoloff, M., Fontecha, M., Forbes, J. F., Howell, A., Cuzick, J.

Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial

- Juraskova, I., Butow, P., Bonner, C., Bell, M. L., Smith, A. B., Seccombe, M., Boyle, F., Reaby, L., Cuzick, J., Forbes, J. F.

Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area

- Isenring, E. A., Capra, S., Bauer, J. D.

Integrin αvβ6-associated ERK2 mediates MMP-9 secretion in colon cancer cells

- Gu, X., Niu, J., Dorahy, D. J., Scott, R. D., Agrez, M. V.

Societal preference values for advanced melanoma health states in the United Kingdom and Australia

- Beusterien, K. M., Szabo, S. M., Kotapati, S., Mukherjee, J., Hoos, A., Hersey, P., Middleton, M. R., Levy, A. R.

Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients

- Khoja, Leila, Kibiro, Minnie, Metser, Ur, Gedye, Craig, Hogg, David, Butler, Marcus O, Atenafu, Eshetu G, Joshua, Anthony M

Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial

- Blinman, Prunella, Mileshkin, Linda, O'Connell, Rachel, Creutzberg, Carien L., Stockler, Martin R., Khaw, Pearly, Goss, Geraldine, Johnson, Carol, Capp, Anne, Brooks, Susan, Wain, Gerard, Kolodziej, Ilka, Veillard, Anne-Sophie

The GOFURTGO study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer

- Goldstein, D., Spry, N., Shapiro, J., Porter, I. W. T., Hruby, G., Horvath, L., Bydder, S., Underhill, C., Harvey, J., Gebski, V. J., Cummins, M. M., Brown, C., van Hazel, G. A., Carroll, S., Selva-Nayagam, S., Borg, M., Ackland, S. P., Wratten, C.

Association of PHB 1630 C > T and MTHFR 677 C > T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

- van der Luijt, B., Devilee, P., EMBRACE,, Easton, D. F., Peock, S., Frost, D., Platte, R., Ellis, S. D., Fineberg, E., Evans, D. G., Lalloo, F., Eeles, R., Jacobs, C., Adlard, J., Davidson, R., Eccles, D., Cole, T., Cook, J., Godwin, A., Bove, B., GEMO Study Collaborators,, Stoppa-Lyonnet, D., Caux-Moncoutier, V., Coupier, I., Peyrat, J.-P., Vennin, P., Muller, D., Fricker, J. P., Venat-Bouvet, L., Johannsson, O. Th., Isaacs, C., Schmutzler, R., Wappenschmidt, B., Meindl, A., Arnold, N., Varon-Mateeva, R., Niederacher, D., Sutter, C., Deissler, H., Preisler-Adams, S., Simard, J., Soucy, P., Durocher, F., Chenevix-Trench, G., Beesley, J., Chen, X., ConFab, K., Rebbeck, T., Couch, F., Wang, X., Lindor, N., Fredericksen, Z., Pankratz, V. S., Peterlongo, P., Bonanni, B., Fortuzzi, S., Peissel, B., Szabo, C., Mai, P. L., Loud, J. T., Lubinski, J., Jakubowska, A., Rozkrut, D., Antoniou, A., Hamann, U., Scott, R. J., McGuffog, L., Healy, S., Sinilnikova, O. M., Rennert, G., Lejbkowicz, F., Flugelman, A., Andrulis, I. L., Glendon, G., Ozcelik, H., Thomassen, M., Paligo, M., Aretini, P., Kantala, J., Aroer, B., Von Wachenfeldt, A., Liljegren, A., Loman, N., Herbst, K., Kristoffersson, U., Rosenquist, R., Karlsson, P., Stenmark-Askmalm, M., Melin, B., Nathanson, K. L., Domchek, S. M., Byrski, T., Huzarski, T., Gronwald, J., Menkiszak, J., Cybulski, C., Serrano, P., Osorio, A., Cajal, T. R., Tsitlaidou, M., Benitez, J., Gilbert, M., Rookus, M., Aalfs, C. M., Kluijt, I., Boessenkool-Pape, J. L., Meijers-Heijboer, H. E. J., Oosterwijk, J. C., Van Asperen, C. J., Blok, M. J., Nelen, M. R., Van Den Ouweland, A. M. W., Seynaeve, C.

Adjuvant chemotherapy in elderly patients with pancreatic cancer

- Nagrial, A. M., Chang, D. K., Pinese, M., Colvin, E. K., Scarlett, C. J., Chou, A., Kench, J. G., Sutherland, R. L., Horvath, L. G., Biankin, A. V., Nguyen, N. Q., Johns, A. L., Chantrill, L. A., Humphris, J. L., Chin, V. T., Samra, J. S., Gill, A. J., Pajic, M.

The needs of patients with advanced, incurable cancer

- Rainbird, K., Perkins, J., Sanson-Fisher, R., Rolfe, I., Anseline, P.

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS Trial

- Pinder, S. E., Duggan, C., Ellis, I. O., Cuzick, J., Forbes, J. F., Bishop, H., Fentiman, I. S., George, W. D.

Adjuvant ovarian function suppression and cognitive function in women with breast cancer

- Phillips, Kelly-Anne, Regan, Meredith, Abdi, Ehtesham, Domchek, Susan, Feng, Yang, Price, Karen, Coates, Alan, Gelber, Richard, Maruff, Paul, Boyle, Frances, Forbes, John F., Ahles, Tim, Ribi, Karin, Fleming, Gini, Bernhard, Jürg, Francis, Prudence A., Puglisi, Fabio, Bellet, Meritxell, Spazzapan, Simon, Karlsson, Per, Budman, Daniel, Zaman, Khalil